Skip to main content
. 2018 May 15;8(1):24–40. doi: 10.1159/000488540

Table 2.

Histopathologic characteristics of HCCs with and without irregular rim-like enhancement, based on the combined results of the two reviewers' classification

Histopathologic features (1) IRE-HCCs (n = 22, 26%) (2) HCCs with intermediate enhancement patterns (n = 11, 13%) (3) Non-IRE-HCCs (n = 51, 61%) p value p value, post hoc*
(1) vs. (2) (2) vs. (3) (1) vs. (3)
Tumor pathology
Tumor diameter, cm 3.4 (2.4–5.2) 2.8 (2.4–4.3) 3.2 (2.4–4.1) 0.693
Histologic differentiation 0.041 0.999 0.999 0.047
 Grade I 0 (0) 0 (0) 8 (16)
 Grade II 14 (64) 9 (82) 37 (73)
 Grade III or IV 8 (36) 2 (18) 6 (12)
Macrotrabecular pattern (% of tumor area) 45 (5–90) 80 (10–90) 0 (0–5) <0.001 0.999 0.003 <0.001
Macrotrabecular-massive type 11 (50) 6 (55) 4 (8) <0.001 0.999 0.003 <0.001
Capsule formation 0.046 0.251 0.999 0.064
 Absent 6 (27) 2 (18) 8 (16)
 Partial 15 (68) 5 (46) 25 (49)
 Complete 1 (5) 4 (36) 18 (35)
Microvascular invasion <0.001 0.006 0.999 <0.001
Absent 2 (9) 7 (64) 33 (65)
Present 20 (91) 4 (36) 18 (35)
Tumor microenvironmental factors
Microvascular density/mm2 246.5±107.5 271.9±171.0 426.5±138.7 <0.001 0.999 0.006 <0.001
Microvascular pattern
 Capillary-like (% of tumor area) 45 (6–75) 90 (10–100) 100 (80–100) <0.001 0.232 0.641 <0.001
 Sinusoid-like (% of tumor area) 55 (20–94) 10 (0–90) 0 (0–20) <0.001 0.232 0.641 <0.001

Tumor necrotic area (% of tumor area) 15 (5–38) 0 (0–30) 0 (0–1.3) <0.001 0.097 0.815 <0.001
Fibrous stromal area (% of tumor area) 8.3 (6.8–13.4) 2.2 (1.1–10.6) 2.1 (1.3–4.7) <0.001 0.074 0.999 <0.001

Immunohistochemical markers
K19 expression 6 (27) 1 (9) 3 (6) 0.034 0.999 0.999 0.055
EpCAM expression 11 (50) 3 (27) 10 (20) 0.031 0.835 0.999 0.026
CAIX expression 14 (64) 7 (64) 4 (8) <0.001 0.999 0.001 <0.001

Numerical variables are expressed as median (interquartile range) or mean ± standard deviation, according to the result of the normality test (Shapiro-Wilk test). Categorical variables are expressed as n (%). HCC, hepatocellular carcinoma; IRE, irregular rim-like enhancement.

*

Adjusted using Bonferroni correction.